Companies: 10,795·Total market cap: $144.5T
Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Company

4016.SRSAUHealthcare● Active
$62.10
$-0.20(-0.32%)
Market Cap$2.2B
P/E Ratio
52W High$79.08572
52W Low$53.88572
Overview

Middle East Pharmaceutical Industries Company(4016.SR)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · 4016.SR · 截至 2026-06-16

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$0.03B$0.02B$0.02B$0.02B$0.02B
Net Receivables$0.26B$0.22B$0.16B$0.16B$0.17B
Inventory$0.10B$0.09B$0.09B$0.10B$0.08B
Total Current Assets$0.41B$0.36B$0.28B$0.29B$0.27B
PP&E Net$0.12B$0.12B$0.12B$0.11B$0.10B
Goodwill$0.00B$0.00B$0.00B$0.00B$0.00B
Intangible Assets$0.06B$0.05B$0.05B$0.04B$0.03B
Total Assets$0.60B$0.53B$0.44B$0.44B$0.42B
Liabilities
Short-Term Debt$0.04B$0.07B$0.06B$0.08B$0.07B
Accounts Payable$0.04B$0.03B$0.03B$0.04B$0.03B
Total Current Liabilities$0.13B$0.13B$0.11B$0.13B$0.12B
Long-Term Debt$0.02B$0.00B$0.00B$0.01B$0.02B
Total Liabilities$0.18B$0.16B$0.14B$0.16B$0.15B
Stockholders Equity
Retained Earnings$0.23B$0.18B$0.13B$0.08B$0.20B
Total Stockholders Equity$0.42B$0.37B$0.31B$0.28B$0.27B
Total Liab & Equity(computed)$0.60B$0.53B$0.44B$0.44B$0.42B
Debt Summary
Total Debt$0.06B$0.07B$0.06B$0.08B$0.09B
Net Debt$0.03B$0.04B$0.04B$0.06B$0.07B

数据来源:Financial Modeling Prep · 最后更新:2026-06-16 · SAR · B

深入了解Middle East Pharmaceutical Industries Company

关于Middle East Pharmaceutical Industries Company(4016.SR)资产负债表

Middle East Pharmaceutical Industries Company总资产$0.60B,现金及短期投资$0.03B,总负债$0.18B,总债务$0.06B,股东权益$0.42B。

常见问题

4016.SR · 4 问

Middle East Pharmaceutical Industries Company总债务$0.06B,净债务$0.03B。

4016.SR total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-16